US Corporate Distress Financial Stress SEC Filings — June 01, 2026

01-06-2026

Aircastle Advisor LLC, a subsidiary of Aircastle LTD, entered into a credit agreement dated May 20, 2026, establishing a term credit facility with a syndicate of lenders led by Fifth Third Bank, ICBC New York Branch, Huntington National Bank, and PNC Capital Markets LLC. The facility is intended for working capital and other corporate purposes, with interest margins of 0.30% for Base Rate Loans and 1.30% for Tranche Rate Loans. However, the filing does not disclose the total credit commitment amount, and the agreement includes standard but restrictive covenants such as minimum interest coverage and consolidated net worth requirements, which may constrain financial flexibility.

• · The credit agreement was executed on May 20, 2026, and filed as an 8-K on June 1, 2026.
• · The facility is a term loan, not a revolving credit line.
• · The agreement includes negative covenants such as restrictions on liens, indebtedness, mergers, affiliate transactions, and change of control.
• · Financial covenants include an Unencumbered Asset Ratio, Minimum Interest Coverage Ratio, and Consolidated Net Worth maintenance.
• · The agreement contains standard events of default and provisions for lender assignment and participation.

01-06-2026

Liberty Star Uranium & Metals Corp. entered into a Securities Purchase Agreement with Monroe Street Capital Partners LP on May 18, 2026, issuing a convertible promissory note with a principal amount of $123,200, including a 10% original issue discount. The note bears 8% interest, matures in one year, and is convertible into common stock. This creates a direct financial obligation for the company.

• · The note matures in one year from the date of the agreement (May 18, 2026).
• · The note is convertible into shares of common stock.
• · The Securities Purchase Agreement is dated April 15, 2026, but the note was issued effective May 26, 2026.
• · The filing includes exhibits: Convertible Promissory Note (Exhibit 3.83) and Securities Purchase Agreement (Exhibit 3.84).

01-06-2026

MoonLake Immunotherapeutics entered into a Master Commercial Supply Agreement and a Capacity Agreement with Vetter Pharma International GmbH on May 22, 2026, for manufacturing of pre-filled application systems. The agreements include binding capacity commitments with minimum and maximum quantities, and potential compensation obligations if MoonLake fails to meet commitments. No financial terms were disclosed.

• · The Vetter MCSA is a master agreement under which product-specific schedules will detail manufacturing services and pricing.
• · Either party may terminate the Vetter MCSA without cause upon 12 months' written notice.
• · Vetter may terminate if MoonLake undergoes a Change of Control to an acquirer not meeting specified criteria; MoonLake may terminate if Vetter is taken over by a competitor in dermatology/inflammatory diseases before end of 2029.
• · The Capacity Agreement requires MoonLake to provide aggregate demand forecasts, with annual demands for the initial term constituting a binding commitment (MoonLake Commitment).
• · MoonLake may be obligated to pay capacity compensation if it fails to order the Minimum Quantity or fails to provide purchase orders.

01-06-2026

FedEx Freight Holding Company, Inc. completed its spin-off from FedEx Corporation on June 1, 2026, and began trading on the NYSE under ticker FDXF. The spin-off was effected through a pro rata distribution of 80.1% of FedEx Freight shares to FedEx stockholders (one FDXF share for every two FDX shares), while FedEx retained 19.9% of shares to be disposed of within 24 months. The company positions itself as the largest pure-play LTL carrier in North America with over 26,000 service center doors, nearly 30,000 vehicles, and 40,000 team members, and expects to join the S&P 500 and Dow Jones Transportation Average. No financial performance data or period-over-period comparisons were provided in this filing.

• · FedEx Freight will join the S&P 500 and Dow Jones Transportation Average.
• · FedEx retained 19.9% of FedEx Freight shares, to be disposed of within 24 months via exchanges for debt repayment or distributions to stockholders.
• · FedEx Freight operates across all 50 U.S. states, Canada, Mexico, Puerto Rico, and the U.S. Virgin Islands.
• · The spin-off distribution ratio was one FDXF share for every two FDX shares held as of May 15, 2026.
• · Financial advisors: Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC; legal counsel: Skadden, Arps, Slate, Meagher & Flom LLP.

01-06-2026

XPO, Inc. entered into Amendment No. 11 to its Credit Agreement on May 29, 2026, implementing a $385 million extension offer that converted $271.1 million of existing Term B-2 and Term B-3 Loans into Extended Term B Loans, while also obtaining $113.9 million in new Incremental Term Loans. The combined 2026 Term Loans (2026 Term Loans) totaling approximately $385 million will form a single class of Term B-4 Loans, with proceeds used for general corporate purposes and to refinance existing debt. The amendment closed on May 29, 2026, with no Event of Default continuing and customary representations and warranties satisfied. This transaction is a material refinancing and extension of XPO's debt maturities, but no period-over-period comparisons or negative performance data are present in this filing.

• · Amendment No. 11 was executed on May 29, 2026, with the closing date on the same date.
• · Lenders had until 12:00 PM ET on May 20, 2026, to accept the Extension Offer.
• · Engagement Letter and Fee Letter for the transaction were dated May 26, 2026, between Borrower, Lead Arrangers, and Co-Managers.
• · Prepayment notices were delivered by Borrower on May 26, 2026, for the prepayment of existing loans in connection with the transaction.
• · Borrower and each Credit Party represented no Default or Event of Default was continuing immediately before or after incurrence of the 2026 Term Loans.
• · The incremental term loans commitment amounts are listed on Schedule 1 (not fully reproduced in filing text)
• · Each Extending Term B Lender waived its right to compensation under Section 2.11(b) of the Credit Agreement with respect to the prepayment, exchange or conversion of its Existing Term B Loans.
• · Since the Amendment No. 10 closing date (Feb 26, 2025), the Company has completed a 11th amendment to its credit agreement.

01-06-2026

IN8bio, Inc. entered into a Capital on Demand Sales Agreement with JonesTrading Institutional Services LLC to issue and sell shares of its common stock from time to time in at-the-market offerings. The agreement allows for aggregate gross sales proceeds up to the lesser of the amount registered on Form S-3 (333-291393), authorized but unissued shares, or the amount permitted under Form S-3. The company will pay the Agent a commission or discount as set forth in Schedule 2 of the agreement.

• · The agreement is filed under Form 8-K items 1.01, 1.02, and 9.01.
• · The Registration Statement on Form S-3 is numbered 333-291393.
• · Sales will be conducted as 'at the market offerings' under Rule 415(a)(4) of the Securities Act.
• · Settlement for sales will occur on the first Trading Day following the sale date.
• · The Company may suspend sales at any time by notice to the Agent, and vice versa.
• · The Agent has no obligation to purchase shares on a principal basis unless otherwise agreed.

01-06-2026

Wheels Up Experience Inc. entered into a $100 million unsecured term loan credit agreement on May 29, 2026, with U.S. Bank Trust Company, N.A. as administrative agent and multiple lenders. The proceeds will be used for working capital, capital expenditures, and general corporate purposes. The loan carries an interest rate of 12% per annum and is guaranteed by the company's subsidiaries.

• · The credit agreement includes negative covenants restricting restricted payments, indebtedness, asset dispositions, affiliate transactions, liens, business activities, mergers, and use of proceeds.
• · Events of default include non-payment, breach of representations, covenant violations, cross-defaults, bankruptcy, and material adverse changes.
• · The loan is unsecured and guaranteed by the borrower's subsidiaries.
• · The agreement was filed as an 8-K on June 1, 2026, with an effective date of May 29, 2026.

01-06-2026

Trilogy Metals Inc. announced an extension of the closing deadline for the previously announced US$35.6M strategic equity investment from the U.S. Department of War (DOW) to July 31, 2026. Key milestones have been completed, including the FOCI risk assessment and the DPA reauthorization, while definitive documentation is progressing. Concurrently, the Arctic Project achieved FAST-41 designation, ensuring a transparent federal permitting timetable, though the investment closing remains delayed, highlighting mixed progress.

• · FOCI risk assessment of Trilogy Metals has been completed by the U.S. Government, allowing finalization of definitive agreements.
• · U.S. Congress reauthorized the Defense Production Act, providing continued statutory foundation for the investment program.
• · The Arctic Project was officially accepted as a 'Covered Project' under FAST-41 on May 15, 2026, triggering statutory permitting timelines.
• · Ambler Metals is a 50/50 joint venture between Trilogy and South32, formed in December 2019.
• · The Arctic Project hosts one of the highest-grade undeveloped copper-zinc-lead-gold-silver deposits in North America.

01-06-2026

IREN Ltd, through its subsidiary IE US Hardware 3 LLC, entered into financing agreements totaling approximately $3.6 billion to partially fund the acquisition of GPU infrastructure supporting its contract with Microsoft. The financing consists of a $1.5 billion delayed draw term loan facility and $2.1 billion in senior notes at 5.96% interest, secured by the subsidiary's assets including the GPUs and cash flows from the Microsoft contract.

• · The financing has a delayed draw availability period until May 29, 2027, with maturity on December 31, 2031.
• · The DDTL bears interest at term SOFR plus 2.25% per annum with a commitment fee of 0.40% per annum on undrawn commitments.
• · Hardware 3 must maintain a debt service coverage ratio of at least 1.05:1.00, tested quarterly.
• · Mandatory prepayment triggers include DSCR below 1.10:1.00 for six consecutive months and loan-to-cost ratio exceeding 65%.
• · Hedge agreements for interest rate and power costs have been entered with JPMorgan and Goldman Sachs affiliates.

01-06-2026

Berkshire Hathaway has agreed to acquire Taylor Morrison Home Corporation for $72.50 per share in an all-cash transaction valued at approximately $6.8 billion in equity and $8.5 billion total enterprise value. The deal represents a 24% premium to Taylor Morrison's closing price of $58.50 on May 29, 2026, and is expected to close in the second half of 2026, subject to shareholder and regulatory approvals. Taylor Morrison will continue to be led by its existing management team, including CEO Sheryl Palmer, and will become a private company upon completion.

• · Taylor Morrison serves entry-level, move-up, and resort lifestyle homebuyers under Taylor Morrison and Esplanade brands, and develops rental communities under Yardly brand.
• · Taylor Morrison also provides financial services including mortgage, title and escrow, and homeowners' insurance.
• · Upon completion, Taylor Morrison will become a private company and its common stock will no longer be listed on the NYSE.
• · Goldman Sachs & Co. LLC and Moelis & Company LLC are serving as financial advisors, Simpson Thacher & Bartlett LLP as legal advisor, and Mayer Brown LLP as financial services regulatory counsel to Taylor Morrison.
• · Taylor Morrison has been recognized as America's Most Trusted Builder by Lifestory Research since 2016, and was honored as one of Fortune's World's Most Admired Companies in 2026.

01-06-2026

Eloxx Pharmaceuticals, Inc. filed a Certificate of Amendment to effect a 1-for-11 reverse stock split of its Common Stock, effective as of 5:00 p.m. Eastern time on the filing date (June 1, 2026). The amendment, approved by stockholders and the Board, reduces the authorized Common Stock from an unspecified prior amount to 100,000,000 shares (par value $0.01) and authorized Preferred Stock remains at 5,000,000 shares. No fractional shares will be issued; holders otherwise entitled to a fractional share will receive a cash payment based on fair market value.

• · The reverse stock split was approved by written consent of stockholders.
• · The amendment was adopted under Section 242 of the Delaware General Corporation Law.
• · The par value of Common Stock remains $0.01 per share after the reverse split.
• · The Board of Directors retains authority to issue Preferred Stock in series with varying rights, including redemption, dividends, and conversion.

01-06-2026

NusaTrip Inc. received a Nasdaq delinquency notice on May 27, 2026 for failing to timely file its Form 10-K for FY2025 and Form 10-Q for Q1 2026, violating Listing Rule 5250(c)(1). The company has 60 days (until July 27, 2026) to submit a compliance plan; if accepted, it may have until October 12, 2026 to regain compliance. While the notice has no immediate delisting effect, failure to regain compliance could result in delisting, and the company expects to file the delinquent reports within the 60-day period.

• · The company is an emerging growth company as defined under SEC rules.
• · The delinquent filings are the Annual Report on Form 10-K for the period ended December 31, 2025 and the Quarterly Report on Form 10-Q for the period ended March 31, 2026.
• · If Nasdaq does not accept the compliance plan, the company may appeal to a Nasdaq Hearings Panel.
• · A press release regarding the notice was issued on June 1, 2026, as required by Nasdaq Listing Rule 5810(b).

01-06-2026

Inotiv, Inc. entered into a Second Supplemental Indenture on May 28, 2026, extending the grace period for a missed interest payment on its 3.25% Convertible Senior Notes due 2027 from 44 to 51 days, now expiring June 5, 2026. The company failed to make a $2.139 million interest payment due April 15, 2026, and has now extended the grace period twice, indicating ongoing liquidity stress.

• · The original grace period was 30 days (through May 15, 2026), extended to 44 days (through May 29, 2026) via a First Supplemental Indenture dated May 15, 2026.
• · The Second Supplemental Indenture extends the grace period to 51 days total, through June 5, 2026.
• · Consents were obtained from holders of a majority in aggregate principal amount of the outstanding Convertible Notes.
• · The filing does not disclose whether the interest payment has been made or if the company has sufficient liquidity to make it by the new deadline.

01-06-2026

HCI Group, Inc. secured comprehensive reinsurance programs for its four insurance subsidiaries for the 2026-2027 treaty year (June 1, 2026 to May 31, 2027) through three fully placed reinsurance towers providing total coverage of up to $1.06 billion, $830.3 million, and $431.5 million per single event, respectively. The company expects net consolidated reinsurance premiums ceded to third parties of approximately $381.2 million, while its captive reinsurers Claddaugh and Fortex Re retain an estimated maximum combined loss of $139.8 million for the first event and $52.3 million for the second event. All private reinsurers are rated 'A-' (Excellent) or better, and the programs include coverage from the Florida Hurricane Catastrophe Fund.

• · All three reinsurance towers are fully placed and satisfy HCI's reinsurance needs for the 2026-2027 treaty year.
• · Reinsurance Tower 1 covers Homeowners Choice policies in central and southern Florida; Tower 2 covers all TypTap policies and Homeowners Choice policies outside Florida; Tower 3 covers Tailrow, CORE, and Homeowners Choice policies in northern Florida.
• · Claddaugh and Fortex Re participations remain subject to approval by the Florida Office of Insurance Regulation.
• · HCI may explore additional risk transfer instruments in the future to further enhance reinsurance protection for the 2026-2027 treaty year.
• · Reinsurance premiums are estimates based on exposure projections and subject to true-up at September 30, 2026.
• · All private reinsurers are AM Best rated 'A-' (Excellent) or better, or have fully collateralized their obligations.
• · The Florida Hurricane Catastrophe Fund agreement covers only storms designated as hurricanes by the National Hurricane Center.

01-06-2026

HCW Biologics Inc. received an extension from the Nasdaq Hearings Panel until July 29, 2026, to regain compliance with the minimum bid price of $1 per share for continued listing on The Nasdaq Capital Market. The company had previously failed the Bid Price Rule and, due to a 1-for-40 reverse stock split on April 11, 2025, was not eligible for the standard 180-day cure period. The extension is subject to strict conditions, including demonstrating a bid price of at least $1 for 20 consecutive trading days by the deadline, with immediate delisting if the deficiency recurs before September 22, 2026.

• · The company was not afforded a 180-calendar day cure period because it had already effected a 1-for-40 reverse stock split on April 11, 2025.
• · If the company becomes deficient with the Bid Price Rule again before September 22, 2026, it will be immediately delisted.
• · If the company becomes non-compliant with any other listing rule before September 22, 2026, it has seven calendar days to propose a cure plan.
• · Upon regaining compliance, the Panel intends to impose a Discretionary Panel Monitor for an additional one-year period.

01-06-2026

Northern Oil and Gas, Inc. (NOG) completed the Parallax Acquisition on June 1, 2026, acquiring certain oil and gas properties and related assets from Parallax Energy Operating Inc. for total consideration of CA$237.0 million in cash (including a CA$37.5 million deposit) and 3,689,413 shares of NOG common stock. The cash portion was funded with cash on hand, operating free cash flow, and borrowings under its revolving credit facility. Concurrently, NOG entered into a Registration Rights Agreement with the seller to facilitate the resale of the stock consideration.

• · The cash portion of the consideration remains subject to final post-closing settlement between Purchaser and Seller.
• · The Stock Consideration was issued in reliance on the exemption from registration under Section 4(a)(2) of the Securities Act of 1933.
• · The Registration Rights Agreement requires NOG to file a shelf registration statement (or prospectus supplement) on Form S-3ASR covering the resale of the Stock Consideration no later than the later of the first business day after closing or three business days after receiving a completed questionnaire from Seller.
• · The material terms of the PSA were previously disclosed in an 8-K filed on May 26, 2026.

01-06-2026

V2X LLC, a subsidiary of V2X, Inc., entered into Amendment No. 6 to its First Lien Credit Agreement on May 29, 2026, refinancing all outstanding 2024 Term B-2 Loans into new 2026 Term Loans with an initial aggregate principal amount of $868,522,978.38. The refinancing was executed with Royal Bank of Canada as administrative agent and includes participation from an additional lender and consenting existing lenders. The amendment became effective upon satisfaction of customary conditions, including repayment of prior loans and delivery of legal opinions and solvency certificates.

• · The amendment is the sixth amendment to the original First Lien Credit Agreement dated December 6, 2021.
• · Prior amendments were dated July 5, 2022, May 31, 2023, October 3, 2023, May 30, 2024, and January 2, 2025.
• · The 2026 Term Loans are guaranteed by the Guarantors and secured by Liens under the Collateral Documents.
• · Conditions for effectiveness included receipt of a solvency certificate from the borrower's CFO and a legal opinion from Reed Smith LLP.
• · The borrower paid all fees and reasonable out-of-pocket expenses to the administrative agent and arrangers.

01-06-2026

Lantronix, Inc. announced the pricing of an underwritten offering of 4,166,667 shares of common stock at $7.20 per share, with gross proceeds of approximately $30 million. The offering is expected to close on or about June 1, 2026, and includes a 30-day underwriter option for up to an additional 625,000 shares. Needham & Company and Canaccord Genuity are acting as joint bookrunners.

• · Offer price per share is $7.20.
• · The offering is made under a shelf registration statement on Form S-3 (File No. 333-284749) declared effective on February 19, 2025.
• · The underwriters have a 30-day option to purchase up to 625,000 additional shares.
• · The offering is expected to close on or about June 1, 2026.

01-06-2026

On May 28, 2026, CitroTech Inc. entered into Exchange Agreements with holders of its Series A Preferred Stock, reacquiring all 1,666,667 outstanding shares of Series A Preferred Stock. In exchange, the company issued 103,558 shares of Series C Convertible Preferred Stock to BoltRock Holdings, LLC at closing and agreed to issue 467,012 shares of Series C Preferred Stock to TC Special Investments LLC after 18 months (or earlier upon a change of control, including the appointment of Theodore S. Ralston to the board). The transaction eliminates the Series A Preferred Stock entirely, but the deferred issuance to TCSI introduces future dilution risk.

• · The Exchange Agreements provide board designation or observer rights to holders while they maintain a 10% stake.
• · BoltRock Holdings receives certain limited consent rights for a period after closing.
• · The Series C Preferred Stock issued carries registration rights.
• · The company relied on Section 4(a)(2) of the Securities Act for exemption from registration.
• · Theodore S. Ralston's appointment to the board would trigger an earlier issuance of the TCSI shares under a change of control provision.

01-06-2026

Barings BDC, Inc. (BBDC) entered into a Termination and Cancellation Agreement with Barings LLC on May 29, 2026, terminating the existing credit support agreement (CSA) originally established in connection with BBDC's acquisition of Sierra Income Corporation. Under the agreement, Barings LLC will make a cash payment of $67,027,611 to BBDC by June 30, 2026, settling obligations on certain investments, while a new CSA for $10,994,928 will be entered into for remaining investments. The settlement covers investments that have been realized, have a fair value of $500,000 or less, or are in an unrealized loss position as of the agreement date.

• · The original CSA was dated February 25, 2022, and provided up to $100 million in credit support for losses on investments acquired from Sierra in connection with the Merger Transaction.
• · The Cash Payment of $67,027,611 is due on or before June 30, 2026.
• · The Settled Obligation covers investments that have been realized, have a fair value of $500,000 or less, or are in an unrealized loss position as of the agreement date.
• · For investments with fair value of $500,000 or less, the settlement amount was calculated as if those investments had zero value.
• · The Cash Payment will be treated as gain attributable to termination of a right with respect to a capital asset for tax purposes under Section 1234A of the Internal Revenue Code.
• · The agreement is governed by New York law.

01-06-2026

Bright Horizons Family Solutions LLC entered into a Fifth Amendment to its Second Amended and Restated Credit Agreement on June 1, 2026, securing $375 million in new Term A Loans and increasing its revolving credit commitments to $1.0 billion. The proceeds from the Term A Loans, together with cash on hand, will be used to repay $375 million of existing revolving credit loans and pay related fees and expenses. The amendment also extends the maturity and adjusts terms of the credit facility, reflecting the company's proactive management of its capital structure.

• · The amendment was executed on June 1, 2026, and is effective upon satisfaction of conditions including delivery of legal opinions, good standing certificates, and no existing default.
• · The 2026 Term A Loans are provided by lenders listed on Schedule I, and the 2026 Revolving Commitment Increase is provided by lenders on Schedule II.
• · The 2026 Term A Loans cannot be reborrowed once repaid or prepaid.
• · The amendment includes reaffirmation of obligations by all Loan Parties under the Loan Documents.
• · The Borrower must provide know-your-customer documentation at least three business days prior to the effective date.

01-06-2026

Encompass Health Corp issued $500M of 5.875% Senior Notes due 2034 on May 29, 2026, with net proceeds of approximately $491.2M. The company plans to use the proceeds to redeem $400M of its existing 4.500% senior notes due 2028, repay $100M under its revolving credit facility, and pay related fees. This refinancing extends the company's debt maturity profile but introduces a higher coupon rate of 5.875% versus the 4.500% on the notes being redeemed.

• · The Notes were issued at par and are senior unsecured obligations, ranking equally with existing senior debt and senior to subordinated debt.
• · The Notes are guaranteed on a senior unsecured basis by all existing and future subsidiaries that guarantee the company's senior secured revolving credit agreement or other capital markets debt.
• · The Indenture includes covenants limiting liens, sale/leaseback transactions, and mergers/asset transfers, with customary exceptions.
• · Upon a change of control, holders can require repurchase at 101% of principal plus accrued interest.
• · Events of default include cross-defaults on indebtedness exceeding $100M and judgments exceeding $100M.
• · The company may redeem up to 40% of the Notes from equity offering proceeds before June 1, 2029, at 105.875% of principal, provided at least 60% remains outstanding.
• · The Notes mature on June 1, 2034, with interest payable semiannually on June 1 and December 1, starting December 1, 2026.

01-06-2026

SM Energy Company redeemed all $419,235,000 of its 6.75% Senior Notes due 2026 on June 1, 2026, plus accrued interest, and terminated the related indenture agreements. This debt retirement reduces the company's leverage and interest expense, but the filing does not disclose the source of funds or any associated costs.

• · The redemption was made pursuant to the Indenture dated May 21, 2015, as amended by the Third Supplemental Indenture (September 12, 2016) and the Sixth Supplemental Indenture (January 30, 2026).
• · All remaining obligations under the Indenture Documents related to the 2026 Senior Notes were satisfied.
• · The redeemed notes and related guarantees were cancelled upon settlement.

01-06-2026

Greenlight Capital Re, Ltd. entered into an Ordinary Share Repurchase Agreement on June 1, 2026, with the David M. Einhorn 2021-07 Family Trust, an affiliate of Chairman David Einhorn, to repurchase shares equal to 33% of the aggregate shares bought under a planned 10b5-1 plan. The agreement aims to prevent Mr. Einhorn's ownership percentage from increasing further due to adverse tax consequences. The repurchase is expected to close on or about August 3, 2026, and the agreement may be terminated if no shares are repurchased by that date.

• · The share repurchase agreement is with the David M. Einhorn 2021-07 Family Trust, an affiliate of Chairman David Einhorn.
• · The purchase price per share will equal the weighted average price per share paid by the company under the 10b5-1 plan, excluding commissions.
• · The agreement may be terminated if the company does not enter the 10b5-1 plan or has repurchased no shares under it by August 3, 2026.

01-06-2026

Trinseo PLC and certain affiliates filed for Chapter 11 bankruptcy on May 26, 2026, and on May 28, 2026, entered into a Senior Secured Super-Priority Debtor-in-Possession (DIP) Credit Agreement with lenders led by Deutsche Bank AG New York Branch. The DIP facility provides new money term loans and rolls up certain prepetition superpriority secured obligations at a ratio of $2 of roll-up loans for every $1 of new money commitments. The agreement includes milestones, liquidity requirements, and other covenants typical for DIP financing, with the loans guaranteed and secured by liens on collateral subject to bankruptcy court orders.

• · The Chapter 11 cases were filed in the United States Bankruptcy Court for the Southern District of Texas, Houston Division (Case No. 26-90545) on May 26, 2026.
• · The DIP facility includes both new money commitments and a roll-up of prepetition superpriority secured obligations at a 2:1 ratio (roll-up to new money).
• · The agreement includes milestones, liquidity covenants, and variance reporting requirements.
• · The Ad Hoc Group of Prepetition Superpriority Lenders is represented by Paul Hastings LLP and PJT Partners LP.
• · The DIP facility is subject to the terms of the DIP Orders (Interim and Final) from the Bankruptcy Court.

01-06-2026

Brandywine Operating Partnership, L.P. and Brandywine Realty Trust notified Bank of America, as Administrative Agent, of their election to extend the Existing Revolving Loan Maturity Date under the Credit Agreement by six months, effective June 30, 2026. The Borrowers certified no Default or Event of Default has occurred and will pay an extension fee equal to 0.0625% of the Revolving Credit Facility to the Lenders pro rata.

• · The extension fee of 0.0625% of the Revolving Credit Facility is payable on or before June 30, 2026.
• · The extension is exercised under Section 3.5 of the Credit Agreement dated June 30, 2022.
• · The filing is an 8-K with Items 1.01 (Entry into Material Agreement), 2.03 (Creation of Direct Financial Obligation), 5.02 (Departure of Directors or Principal Officers), 5.07 (Submission of Matters to Vote), and 9.01 (Financial Statements and Exhibits).
• · No Default or Event of Default was continuing as of the date of the notice (May 28, 2026).

01-06-2026

Veralto Corporation issued $725 million aggregate principal amount of 4.850% Senior Notes due 2032 in an underwritten offering, receiving net proceeds of approximately $718.8 million after underwriting discount and expenses. The company intends to use the net proceeds for general corporate purposes, which may include refinancing of outstanding indebtedness, working capital, capital expenditures, and satisfaction of other obligations. The notes are unsecured, unsubordinated obligations and contain certain covenants limiting secured debt, sale and leaseback transactions, and asset transfers.

• · The Notes were issued under a registration statement on Form S-3ASR (File No. 333-282816) filed on October 24, 2024.
• · Interest on the Notes will be paid semi-annually on January 15 and July 15, beginning January 15, 2027.
• · The Notes mature on January 15, 2032.
• · Prior to December 15, 2031 (Par Call Date), the company may redeem the Notes at a make-whole price based on Treasury Rate plus 15 basis points; on or after that date, at 100% of principal plus accrued interest.
• · Upon a change of control triggering event, holders may require repurchase at 101% of principal plus accrued interest.
• · The Notes are effectively subordinated to all secured indebtedness of the company and structurally subordinated to liabilities of subsidiaries.
• · The Indenture contains covenants limiting incurrence of certain secured debt, sale and leaseback transactions, and mergers or asset transfers.

01-06-2026

Nuburu, Inc. entered into an Investment Agreement with Tekne S.p.A. and its shareholders to acquire a 70% equity interest in Tekne. The deal involves a €29,692,000 subscription price (including a convertible receivable of €17,692,000 and up to €12,000,000 in additional funding) and a €5,200,000 cash payment plus an earn-out of up to €29,692,000 based on 5% of Tekne's annual revenues from 2027 to 2036. The transaction is subject to Italian government approval under the Golden Power Regulations by September 30, 2026, and if not obtained, the agreement will terminate and the convertible receivable must be repaid.

• · The Agreement was signed on May 26, 2026, and filed on June 1, 2026.
• · If GP Authorization is not received by September 30, 2026, the agreement terminates and Tekne must repay the convertible receivable within 30 business days, or in 60 equal monthly installments under certain circumstances.
• · During the Interim Period, Tekne cannot undertake actions outside ordinary business without Nuburu Defense's consent.
• · If Tekne's equity is negative before closing, shareholders must restore net equity to at least the statutory minimum.
• · The earn-out can be paid in cash or Nuburu common stock at the company's option, with share count based on 20-day VWAP before the 10-K filing date.
• · Shareholders have agreed to non-compete clauses for as long as they hold Tekne shares.

01-06-2026

BlockchAIn Digital Infrastructure, Inc. (AIB) announced a 15-year Electric Service Agreement (ESA) to expand its contracted utility load at the CLT-01 data center campus from 40 MW to 65 MW, with the full 65 MW immediately available through existing 34.5 kV infrastructure requiring no significant electrical upgrades. The expanded capacity supports a growing customer pipeline including letters of intent for 25 MW of committed critical IT load from a leading AI company and a financial institution. However, the remaining phase of infrastructure expansion (a new AI-optimized data center shell) is expected to take up to nine months to complete, and the company faces execution risks including permitting delays, contractor performance, and the ability to convert letters of intent into definitive contracts.

• · The expanded power load represents the first phase of the site's broader infrastructure expansion; the second phase (new data center shell) is expected to be completed in nine months.
• · Christopher Iannacone, former Director of Project Management at Amazon with 25+ years of experience overseeing 3+ gigawatts of data center capacity, will lead project execution.
• · The company's business development team includes Eyal Rozen (former Nebius executive) and Gary Heitz (former Google and Dell business development leader).
• · The press release contains forward-looking statements and cautions that actual results may differ materially due to risks including utility counterparty performance, permitting delays, tariff changes, and market conditions.

01-06-2026

BlackRock TCP Capital Corp. (TCPC) entered into a placement agency agreement with Scotia Capital (USA) Inc. on May 27, 2026, for the issuance and sale of secured notes. The notes will be secured by a portfolio of U.S. dollar-denominated senior secured middle market loans, with BlackRock Capital Investment Advisors, LLC acting as investment manager. The offering is exempt from registration under the Securities Act, targeting qualified institutional buyers and qualified purchasers.

• · The offering circulars were dated April 1, 2026 (preliminary), April 29, 2026 (second preliminary), and May 26, 2026 (final).
• · The placement agent will receive a structuring and arrangement fee per an engagement letter dated April 23, 2026.
• · The notes will be issued under an indenture to be dated as of the closing date.
• · The issuer represents no material adverse change since the dates in the offering documents.

01-06-2026

PennantPark Floating Rate Capital Ltd. (PFLT) issued $105 million aggregate principal amount of 7.375% Notes due 2031, including $5 million from the partial exercise of the underwriters' over-allotment option. The net proceeds of approximately $101.19 million will be used to repay outstanding revolving credit facility obligations, invest in portfolio companies, and for general corporate purposes. The notes are unsecured and rank pari passu with existing and future unsecured unsubordinated debt, but are effectively subordinated to secured indebtedness.

• · The Notes mature on June 15, 2031 and may be redeemed at the Company's option on or after June 15, 2028.
• · Interest on the Notes is payable quarterly in arrears on March 15, June 15, September 15, and December 15, commencing September 15, 2026.
• · The Notes are expected to be listed on the New York Stock Exchange under the symbol 'PFLA' within 30 days of the original issue date.
• · The Indenture includes covenants requiring asset coverage compliance under the Investment Company Act of 1940 and restrictions on dividends/distributions if asset coverage falls below specified thresholds.
• · The offering was made under a Registration Statement on Form N-2 (File No. 333-279726) with prospectus supplements dated May 27, 2026.

01-06-2026

Seritage Growth Properties (SRG-PA) subsidiary entered into an option purchase and sale agreement (PSA) on June 1, 2026, to sell a property in Dallas, Texas for $50,760,000. The buyer made an initial option payment of $169,200, with escalating monthly payments through January 2028 if the option remains active. However, the sale is contingent on the buyer obtaining entitlements and is cross-conditioned with a related PSA for an adjacent property, and there are no assurances the option will be exercised.

• · The closing date is the earlier of 90 days after the Entitlements Period Expiration Date or January 31, 2028.
• · The Entitlements Period Expiration Date is the earlier of January 28, 2028, or the date the buyer obtains entitlements for intended use.
• · The PSA is cross-conditioned and cross-defaulted with a related PSA for an adjacent property owned by unaffiliated parties.
• · All option payments are incremental to the purchase price and non-refundable except as otherwise provided.
• · The PSA is subject to customary closing conditions.

01-06-2026

iSpecimen Inc. (ISPC) received a delisting notice from Nasdaq on May 29, 2026, for failing to meet the minimum $2,500,000 stockholders' equity requirement under Listing Rule 5550(b)(1). As of March 31, 2026, the company reported stockholders' equity of only $814,038, and Nasdaq noted it also fails alternative listing standards. The company has 45 days to submit a compliance plan and may receive up to 180 days to regain compliance, but there is no assurance of acceptance or ultimate compliance.

• · The company's common stock continues to trade on Nasdaq Capital Market under symbol 'ISPC' with no immediate effect on listing or trading.
• · If Nasdaq rejects the compliance plan, iSpecimen has the opportunity to appeal to a Nasdaq Hearings Panel.

01-06-2026

Enviri II Corporation (New Enviri) launched as a standalone public company on June 1, 2026, following the completion of the sale of Clean Earth to Veolia. The company expects annualized 2026 pro forma revenues of approximately $1.2 billion and Adjusted EBITDA of $140 million, with a conservative capital structure (Net Debt/Adjusted EBITDA of 2.0x) and an undrawn revolving credit facility. However, the Harsco Rail segment is projected to have negative Adjusted EBITDA of -$23 million in 2026, and the company faces significant risks from market cyclicality, customer concentration, and execution of its turnaround plan.

• · New Enviri common stock begins Regular Way trading on NYSE under ticker 'NVRI' on June 2, 2026.
• · The company will be renamed 'Enviri Corporation'.
• · Harsco Environmental pro forma operating income is projected at $59 million for the twelve months ending December 31, 2026.
• · Harsco Rail pro forma operating loss is projected at -$29 million for the same period.
• · Corporate pro forma operating loss is projected at -$30 million.
• · Strategic costs of $12 million and stock-based compensation of $4 million are included in the Adjusted EBITDA reconciliation.
• · Depreciation and amortization total $122 million ($120 million depreciation + $2 million amortization).
• · The spin-off and sale were announced on November 21, 2025.
• · Advisors included BofA Securities, Jefferies, Fried Frank, and Joele Frank.

01-06-2026

LiqTech International entered into a Debt Cancellation Agreement with affiliates of Bleichroeder L.P. and other note holders to settle $6.0 million in senior promissory notes. The agreement provides for a $3.0 million stock-for-debt swap at the public offering price and $3.0 million cash payment plus accrued interest, fully extinguishing the notes upon the closing of an underwritten public offering.

• · Senior promissory notes were originally issued on June 22, 2022, and amended on October 13, 2023 and March 26, 2025.
• · Note holders will receive resale registration rights for shares issued in the stock-for-debt exchange.
• · The shares to be issued are being offered under exemption from registration (Section 4(a)(2) and Rule 506(b)).
• · Debt cancellation is contingent on closing of the public offering.

01-06-2026

Karman Holdings Inc. disclosed a significant increase in its active pipeline to approximately $3B, up from $1B, driven by a generational opportunity set in hypersonics, strategic missile defense, and maritime defense. The company is positioned for over $1B in contract value on high-priority programs, including long-term framework agreements totaling ~$500M in hypersonics and ~$700M in tactical missiles. However, the filing notes that figures are not final and reflect total potential contract value over multiple years, with no current period revenue or profit data provided.

• · FY2026 budget request includes $6.5B for conventional and hypersonic munitions and over $3.9B in hypersonic weapons.
• · The U.S. Navy is racing to rebuild its undersea fleet to maintain strategic advantage.
• · The filing notes that figures are not final and values reflect total potential contract value over multiple years.

01-06-2026

Generation Income Properties, Inc. (GIPRW) announced the pricing of a best-efforts public offering of 23,825,000 shares of common stock (or pre-funded warrants) and warrants to purchase up to 23,825,000 shares of common stock at a combined public offering price of $0.21 per share and accompanying warrant. Gross proceeds are expected to be approximately $5.0 million, with the offering expected to close on or about June 1, 2026. The warrants have an exercise price of $0.21 per share, are exercisable immediately, and expire five years from issuance.

• · The offering is being made pursuant to a registration statement on Form S-11 (File No. 333-296210), declared effective by the SEC on May 28, 2026.
• · Maxim Group LLC is acting as sole placement agent.
• · The warrants are subject to adjustment in connection with share splits or share combinations.
• · The offering is a best-efforts offering, not a firm commitment underwriting.

01-06-2026

Kun Peng International Ltd. filed a Form 8-K on June 1, 2026, reporting amendments to its charter and bylaws under Items 3.03, 5.03, and 8.01. The filing indicates material corporate governance changes, though no specific financial figures or operational metrics were disclosed. No period-over-period comparisons are available as the filing is purely structural.

• · The filing covers Items 3.03 (Material Modification to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws), and 8.01 (Other Events).
• · The company has undergone multiple name changes, formerly known as CX Network Group, Inc. (through 2021-11-03) and mLight Tech, Inc. (through 2017-07-12).
• · The company's fiscal year ends on September 30, and it is classified under SIC 8200 (Educational Services).

01-06-2026

Noble Corporation plc announced a proposed offering of $500 million in senior notes due 2034, with proceeds to redeem all outstanding 8.500% Senior Secured Second Lien Notes due 2030. The offering is subject to market conditions and the redemption is conditioned on completion of the offering.

• · The Notes are unsecured and guaranteed by certain restricted subsidiaries.
• · Offering is made to QIBs under Rule 144A and outside US under Regulation S.
• · Redemption is conditioned on completion of the offering.

01-06-2026

Rallybio Corporation (RLYB) and Avenzo Therapeutics announced a definitive merger agreement where Rallybio will acquire Avenzo, with the combined company operating as Avenzo Therapeutics and trading under ticker 'AVZO'. The transaction includes a concurrent oversubscribed private placement financing of $215 million from leading healthcare investors, expected to fund operations into late 2028. Pre-Transaction Rallybio equityholders will own approximately 2.8% of the combined company, while Avenzo equityholders (including financing participants) will own approximately 97.2%, reflecting a significant dilution for existing Rallybio shareholders.

• · The merger is expected to close in Q4 2026, subject to stockholder approvals and SEC registration statement effectiveness.
• · Rallybio intends to distribute substantially all of its pre-closing net cash to its pre-closing stockholders, and pre-closing Rallybio stockholders will receive contingent value rights (CVRs) for proceeds from the sale of REV102 program interests and other legacy assets.
• · Avenzo plans to present updated safety and efficacy results from AVZO-021 Phase 1 portion at the 2026 ASCO Annual Meeting later today.
• · Preliminary updated data for AVZO-023 in combination with fulvestrant from ORION-1 Phase 1 is expected in late 2026.
• · Preliminary updated data from AVENTINE-1 Phase 1 and initial data from BEACON-1 Phase 1 are expected in late 2026.
• · The combined company expects to fund operations into late 2028 and support advancement through multiple clinical milestones including updated Phase 1 data, initial combination data, and initiation of multiple Phase 2 studies.

01-06-2026

zSpace, Inc. entered into a debt restructuring agreement with holder 3i, LP on May 28, 2026. The agreement converts $2,000,000 of outstanding principal and owed amounts from two senior secured convertible notes into common stock at a conversion price equal to 150% of the closing price on the trading day prior to closing. The remaining Second Note principal of $4,301,075 will be amended with a 9-month conversion moratorium and repaid in 9 equal monthly installments starting 9 months after closing. The restructuring is conditioned on a simultaneous restructuring with Fiza Investments Limited.

• · The conversion price is fixed at 150% of the closing price on the trading day immediately preceding the Closing Date.
• · The Second Note amendment includes a 9-month conversion moratorium and a repayment schedule of 9 equal monthly installments starting 9 months after closing.
• · The restructuring is conditioned on the simultaneous closing of the Fiza Restructuring with Fiza Investments Limited, which must be on terms no more favorable than those in this agreement.
• · The First Note will be fully satisfied and canceled upon closing.
• · Conversion shares are restricted securities and subject to resale restrictions under Regulation S, Rule 144, or other exemptions.
• · A beneficial ownership limitation of 4.99% (9.99% after June 20, 2026) applies to the issuance of conversion shares.

01-06-2026

Optimum Communications (OPTU) has launched a major capital structure repositioning by forming a new unrestricted subsidiary (Unsub Topco) to hold its Optimum East Cable business and 50.01% stake in Lightpath, insulating these assets from the $21.8 billion debt burden at its subsidiary CSC Holdings, of which $6.2 billion matures in 2027. The new subsidiary raised $500M through a $300M private placement of preferred units to institutional investors and a $200M exchange of preferred units for Optimum stock held by controlling stockholder Next Alt S.à r.l. at $2.50/share. Concurrently, a cash tender offer for up to $300M of Optimum common stock at $2.50/share has commenced. While these transactions aim to protect stakeholder value and facilitate consensual debt restructuring negotiations, the company faces a potential multi-billion-dollar tax liability exceeding $4 billion if a restructuring triggers a deconsolidation event, and the CSC Holdings debt maturity cliff in 2027 presents significant refinancing risk.

• · Co-Op Group holds approximately 99% of CSC Holdings Debt and has a Cooperation Agreement that prevents individual restructuring deals, severely limiting traditional refinancing options.
• · Unsub Topco structure was implemented in compliance with existing CSC Holdings debt documents and does not impact day-to-day operations, employees, management team, or board composition.
• · If significantly fewer shares are tendered than the $300M maximum, Unsub Topco plans to conduct a registered public exchange offering preferred units on similar economic terms.
• · Optimum is not a guarantor or obligor under CSC Holdings Debt — it is a holding company.
• · Advisors: Evercore (placement agent), Altman Solon LP (industry consultant), White & Case and Quinn Emanuel (legal counsel).

01-06-2026

AirJoule Technologies Corp. announced a registered direct offering of 3,658,536 shares of common stock to institutional investors, expected to raise gross proceeds of approximately $15.0 million. Net proceeds, together with existing cash, are expected to fully fund the company into 2028 and support commercialization of its AirJoule Core and Prime systems. The offering closed on June 1, 2026, with Titan Partners acting as sole placement agent.

• · The offering was made under an effective shelf registration statement on Form S-3 (File No. 333-291527) filed with the SEC on November 14, 2025, and declared effective on November 21, 2025.
• · The company has a joint venture with GE Vernova and a partnership with Carrier Global Corporation.
• · Titan Partners, a division of American Capital Partners, acted as sole placement agent.

01-06-2026

ClearSign Technologies Corporation (Nasdaq: CLIR) announced a proposed underwritten public offering of its common stock, with Newbridge Securities Corporation acting as sole book-running manager. The company intends to use net proceeds for working capital, R&D, marketing, and general corporate purposes. The offering is subject to market conditions, and there is no assurance as to its completion, size, or terms.

• · The offering is being made under a shelf registration statement (Form S-3, File No. 333-288736) previously filed and declared effective.
• · A preliminary prospectus supplement was filed with the SEC on May 28, 2026.
• · The underwriter has a 30-day option to purchase up to an additional 15% of the shares offered.
• · Use of proceeds includes working capital, research and development, marketing and sales, and general corporate purposes.

01-06-2026

CONMED Corp entered into a First Omnibus Amendment and Increased Facility Activation Notice on May 27, 2026, to amend its existing credit agreement and guarantee and collateral agreement. The amendment includes $450 million in incremental Term A-2 Loans (delayed draw term loans) and reaffirms existing guarantees and security interests. The transaction is subject to customary closing conditions.

• · The amendment modifies the Eighth Amended and Restated Credit Agreement dated June 10, 2025 and the Amended and Restated Guarantee and Collateral Agreement dated June 10, 2025.
• · The Term A-2 Loans are delayed draw term loans, with commitments from lenders listed on Schedule 1 of the amendment.
• · The amendment includes a reaffirmation of guarantees, pledges, and security interests by the parent borrower and loan parties.
• · Effectiveness is subject to conditions including delivery of legal opinions, solvency certificate, and no default or event of default.

01-06-2026

INNOVATE Corp. (VATE) announced the successful closing of a $105M loan to refinance its Broadcasting segment, and entered a merger agreement to sell a 75% controlling interest in Broadcasting to CONX CORP. The refinancing fully satisfied existing notes and funded equity repurchases, while CONX committed up to $75M in equity post-closing. However, INNOVATE will retain only a 25% stake, representing a strategic reduction in ownership of its largest portfolio of TV licenses.

• · The new loan matures on May 29, 2027, but may be accelerated per its terms.
• · For 18 months after closing, INNOVATE can purchase up to 15% of Broadcasting's fully diluted ownership from CONX.
• · CONX Affiliate holds a two-year option to acquire up to 80.1% of Broadcasting's equity, which could force INNOVATE to sell its remaining stake first.
• · Broadcasting operates the largest portfolio of Class A and LPTV licenses in the U.S.
• · The transaction has been approved by the Boards of Directors of both INNOVATE and CONX.
• · INNOVATE employs approximately 3,700 people across its subsidiaries.

01-06-2026

Edgewise Therapeutics announced the sale of sevasemten and its muscular dystrophy business to Servier for up to $2.65 billion, including $1.55 billion in upfront cash and up to $1.1 billion in milestones. The transaction strengthens Edgewise's balance sheet and refocuses the company on its cardiovascular pipeline (EDG-7500, EDG-15400, EDG-003). However, the company is divesting its late-stage muscular dystrophy program and will now rely entirely on earlier-stage cardiovascular assets, with no approved products or revenue to date.

• · Transaction unanimously approved by boards of both companies; expected to close in Q3 2026.
• · All Edgewise employees primarily supporting muscular dystrophy business will receive comparable offers at Servier.
• · Sevasemten has FDA Orphan Drug Designation for Becker and Duchenne, Rare Pediatric Disease Designation for Duchenne, Fast Track designations for both, and EMA Orphan Drug Designations for both.
• · GRAND CANYON pivotal cohort in Becker is fully enrolled with 175 participants, powered at >98% to show statistically significant difference vs placebo; top-line data expected Q4 2026.
• · Edgewise plans to report 12-week Part D data from CIRRUS-HCM Phase 2 trial of EDG-7500 in Q2 2026; Phase 3 initiation targeted for Q4 2026.
• · Edgewise remains on track to initiate a Phase 2 trial of EDG-15400 in HFpEF.
• · Upfront proceeds combined with existing cash expected to fully fund EDG-7500 development through potential approval.
• · Edgewise has no approved products and has not generated any revenue to date.

01-06-2026

System1, Inc. entered into a debt exchange agreement with all its existing lenders to strengthen its capital structure and reduce total debt. The transaction will replace $302.6 million of existing term loan and revolver debt with a new $150.0 million term loan maturing in 2031, $39.3 million in convertible preferred stock, and a $31.4 million cash payment. While the exchange reduces total indebtedness by over $160 million and extends maturities to 2031, it adds convertible preferred stock that may dilute common shareholders and requires shareholder approval along with a one-time cash outflow.

• · Existing term loan maturity: July 2027; revolving credit facility maturity: January 2027; new term loan maturity: January 2031.
• · Transaction expected to close in Q3 2026, subject to shareholder approval at the annual shareholder meeting.
• · Convertible preferred stock is subject to redemption in January 2031.
• · 100% lender participation in the exchange agreement.
• · Management hosted a conference call at 5:00 PM ET on June 1, 2026.
• · The company's common stock trades under the ticker SST on the NYSE; the press release is filed as Exhibit 99.1 to the 8-K.

01-06-2026

CONX Corp. (Parent) has entered into a definitive Agreement and Plan of Merger to acquire HC2 Broadcasting Holdings Inc. (the Company) through a merger of its wholly owned subsidiary, HC2 Merger Sub, LLC, with and into the Company. The transaction, dated May 29, 2026, involves the conversion of Company shares into Surviving Corporation stock and the issuance of Parent Equity Interests in exchange for extinguishing an SPV LLC loan and funding equity commitments. No specific financial amounts or performance metrics are disclosed in this filing.

• · The Merger will be effected under the DGCL and DLLCA, with the Surviving Corporation being HC2 Broadcasting Holdings Inc.
• · Post-merger, the board of the Surviving Corporation will consist of two directors designated by Parent and one by the Company.
• · Concurrently with the agreement, SPV LLC extended a loan to the Company to satisfy all outstanding Existing Debt and terminate it, extinguishing related equity interests.
• · Parent has entered into two Equity Commitment Letters (First and Second) providing third-party beneficiary rights to Seller.
• · An Option Agreement was also entered into among Parent, SPV LLC, the Company, Seller, and Innovate Corp.

01-06-2026

Dropbox announced a new $400M senior secured revolving credit facility with JPMorgan Chase and other banks, and authorized a $900M stock repurchase program. The company has over 700 million registered users across 180 countries.

• · Credit facility with JPMorgan Chase as Administrative Agent, Collateral Agent, Joint Lead Arranger and Bookrunner.
• · Proceeds may be used for working capital, general corporate purposes, including share repurchases.
• · Company has employees around the world and is headquartered in San Francisco, CA.